News

AstraZeneca announced the successful completion of the acquisition of Gracell Biotechnologies Inc , a global clinical-stage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune diseases, furthering AstraZeneca’s cell therapy ambition. The acquisition enriches AstraZeneca’s growing...

Viatris Inc. a global healthcare company, announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimized Risk of Antimicrobial Resistance (AMR). The standard was facilitated by BSI...

A team led by University College Dublin (UCD) has been working on an innovative research initiative that could transform pre-eclampsia diagnosis. It is designed to support clinicians to make effective and efficient clinical diagnosis of suspected pre-eclampsia through intelligent...

In light of the upcoming International Women’s Day, PharmaLinea has announced the publication of a new clinical study, addressing one of the most pressing global health issues for women – recurring urinary tract infections (UTIs). UTIs are highly prevalent...

Big Pharma goes on to drive the demand for contract resource organizations- CROs by way of outsourcing almost 45% of research and development activities. It is well to be noted that the global biotechnology as well as pharmaceutical services...

The quite hectic journey so as to bring a single new drug to the market essentially spans a decade as well as costs an average of $2.6 billion. The AI as well as computing revolutions, however, happen to be...

The pharmaceutical sector is looking for certain transformative strategies so as to stay ahead in an era that is marked by fast technological growth as well as increasing stress when it comes to environmental consciousness. This endeavor has led...